Elekta and Merck & Co to create health monitor for RCC
Digital health monitoring firm Elekta has partnered with US pharmaceutical firm Merck & Co to develop patient monitoring for people with renal cell carcinoma (RCC)3 Apr 2024
Oliver Cuenca